These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

171 related articles for article (PubMed ID: 35187035)

  • 21. Enteral omega-3 fatty acid supplementation in adult patients with acute respiratory distress syndrome: a systematic review of randomized controlled trials with meta-analysis and trial sequential analysis.
    Zhu D; Zhang Y; Li S; Gan L; Feng H; Nie W
    Intensive Care Med; 2014 Apr; 40(4):504-12. PubMed ID: 24556914
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Patient education in the management of coronary heart disease.
    Anderson L; Brown JP; Clark AM; Dalal H; Rossau HK; Bridges C; Taylor RS
    Cochrane Database Syst Rev; 2017 Jun; 6(6):CD008895. PubMed ID: 28658719
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Marine omega-3 fatty acid supplementation and prevention of cardiovascular disease: update on the randomized trial evidence.
    Bassuk SS; Manson JE;
    Cardiovasc Res; 2023 Jun; 119(6):1297-1309. PubMed ID: 36378553
    [TBL] [Abstract][Full Text] [Related]  

  • 24. ω-3 Polyunsaturated Fatty Acid Biomarkers and Coronary Heart Disease: Pooling Project of 19 Cohort Studies.
    Del Gobbo LC; Imamura F; Aslibekyan S; Marklund M; Virtanen JK; Wennberg M; Yakoob MY; Chiuve SE; Dela Cruz L; Frazier-Wood AC; Fretts AM; Guallar E; Matsumoto C; Prem K; Tanaka T; Wu JH; Zhou X; Helmer C; Ingelsson E; Yuan JM; Barberger-Gateau P; Campos H; Chaves PH; Djoussé L; Giles GG; Gómez-Aracena J; Hodge AM; Hu FB; Jansson JH; Johansson I; Khaw KT; Koh WP; Lemaitre RN; Lind L; Luben RN; Rimm EB; Risérus U; Samieri C; Franks PW; Siscovick DS; Stampfer M; Steffen LM; Steffen BT; Tsai MY; van Dam RM; Voutilainen S; Willett WC; Woodward M; Mozaffarian D;
    JAMA Intern Med; 2016 Aug; 176(8):1155-66. PubMed ID: 27357102
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Effects of omega-3 polyunsaturated fatty acids supplementation for patients with cardiovascular disease risks: a dose-response meta-analysis.
    Xie L; Zhen P; Wei Q; Yu F; Song S; Tong J
    Am J Transl Res; 2021; 13(8):8526-8539. PubMed ID: 34539977
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Association between B vitamins supplementation and risk of cardiovascular outcomes: a cumulative meta-analysis of randomized controlled trials.
    Zhang C; Wang ZY; Qin YY; Yu FF; Zhou YH
    PLoS One; 2014; 9(9):e107060. PubMed ID: 25238614
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Effects of ω-3 Polyunsaturated Fatty Acids on Coronary Atherosclerosis and Inflammation: A Systematic Review and Meta-Analysis.
    Gao Z; Zhang D; Yan X; Shi H; Xian X
    Front Cardiovasc Med; 2022; 9():904250. PubMed ID: 35795375
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Long-term effect of high dose omega-3 fatty acid supplementation for secondary prevention of cardiovascular outcomes: A meta-analysis of randomized, placebo controlled trials [corrected].
    Casula M; Soranna D; Catapano AL; Corrao G
    Atheroscler Suppl; 2013 Aug; 14(2):243-51. PubMed ID: 23958480
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Coronary Heart Disease (CHD) in Elderly Patients: Which Drug to Choose, Ticagrelor and Clopidogrel? A Systematic Review and Meta-Analysis of Randomized Controlled Trials.
    Akkaif MA; Sha'aban A; Daud NAA; Yunusa I; Ng ML; Sk Abdul Kader MA; Noor DAM; Ibrahim B
    J Cardiovasc Dev Dis; 2021 Sep; 8(10):. PubMed ID: 34677192
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Aspirin for prophylactic use in the primary prevention of cardiovascular disease and cancer: a systematic review and overview of reviews.
    Sutcliffe P; Connock M; Gurung T; Freeman K; Johnson S; Kandala NB; Grove A; Gurung B; Morrow S; Clarke A
    Health Technol Assess; 2013 Sep; 17(43):1-253. PubMed ID: 24074752
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Anti-inflammatory Therapies for Coronary Heart Disease: A Systematic Review and Meta-Analysis.
    Wang H; Jiang M; Li X; Zhao Y; Shao J; Liu Z; Lin L; Xu Q; Wang L; Lu X; Zhang H; Chen Y; Zhang R
    Front Cardiovasc Med; 2021; 8():726341. PubMed ID: 34513960
    [No Abstract]   [Full Text] [Related]  

  • 32. The effects of calcium supplementation on verified coronary heart disease hospitalization and death in postmenopausal women: a collaborative meta-analysis of randomized controlled trials.
    Lewis JR; Radavelli-Bagatini S; Rejnmark L; Chen JS; Simpson JM; Lappe JM; Mosekilde L; Prentice RL; Prince RL
    J Bone Miner Res; 2015 Jan; 30(1):165-75. PubMed ID: 25042841
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Effects of omega-3 fatty acid on major cardiovascular outcomes: A systematic review and meta-analysis.
    Yu F; Qi S; Ji Y; Wang X; Fang S; Cao R
    Medicine (Baltimore); 2022 Jul; 101(30):e29556. PubMed ID: 35905212
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Association Between Omega-3 Fatty Acid Treatment and Atrial Fibrillation in Cardiovascular Outcome Trials: A Systematic Review and Meta-Analysis.
    Jia X; Gao F; Pickett JK; Al Rifai M; Birnbaum Y; Nambi V; Virani SS; Ballantyne CM
    Cardiovasc Drugs Ther; 2021 Aug; 35(4):793-800. PubMed ID: 34057665
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Omega-3 supplementation and cardiovascular disease: formulation-based systematic review and meta-analysis with trial sequential analysis.
    Rizos EC; Markozannes G; Tsapas A; Mantzoros CS; Ntzani EE
    Heart; 2021 Jan; 107(2):150-158. PubMed ID: 32820013
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Cardiovascular outcomes associated with SGLT-2 inhibitors versus other glucose-lowering drugs in patients with type 2 diabetes: A real-world systematic review and meta-analysis.
    Li CX; Liang S; Gao L; Liu H
    PLoS One; 2021; 16(2):e0244689. PubMed ID: 33606705
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Antibiotics for secondary prevention of coronary heart disease.
    Sethi NJ; Safi S; Korang SK; Hróbjartsson A; Skoog M; Gluud C; Jakobsen JC
    Cochrane Database Syst Rev; 2021 Feb; 2(2):CD003610. PubMed ID: 33704780
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Prognostic Significance of Triglyceride-Glucose Index for Adverse Cardiovascular Events in Patients With Coronary Artery Disease: A Systematic Review and Meta-Analysis.
    Luo JW; Duan WH; Yu YQ; Song L; Shi DZ
    Front Cardiovasc Med; 2021; 8():774781. PubMed ID: 34926622
    [No Abstract]   [Full Text] [Related]  

  • 39. Effect of Omega-3 Polyunsaturated Fatty Acids on Cardiovascular Outcomes in Patients with Diabetes: A Meta-analysis of Randomized Controlled Trials.
    Huang L; Zhang F; Xu P; Zhou Y; Liu Y; Zhang H; Tan X; Ge X; Xu Y; Guo M; Long Y
    Adv Nutr; 2023 Jul; 14(4):629-636. PubMed ID: 37121469
    [TBL] [Abstract][Full Text] [Related]  

  • 40.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.